Advanced Implantable TTFields Delivery System

Publication ID: 24-11857782_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Advanced Implantable TTFields Delivery System,” Published Technical Disclosure No. 24-11857782_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857782_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,782.

Summary of the Inventive Concept

An innovative system for delivering Tumor Treating Fields (TTFields) using implantable transducer arrays with enhanced performance, safety, and patient comfort.

Background and Problem Solved

The original Optune system for delivering TTFields has limitations, including high power consumption, frequent battery replacements, and potential overheating of electrode elements. The new inventive concept addresses these issues by introducing reduced power consumption, cooling systems, and modular designs, ensuring improved treatment efficacy and patient comfort.

Detailed Description of the Inventive Concept

The advanced implantable TTFields delivery system comprises multiple implantable transducer arrays, each configured to operate at reduced power consumption, minimizing electrical resistance and overheating risks. The arrays are designed with a cooling system to prevent overheating of electrode elements, ensuring safe and efficient treatment. The system also features modular components, allowing for easy replacement or upgrade of individual parts, reducing maintenance costs and downtime. Additionally, the arrays can adjust their frequency and amplitude in real-time based on feedback from sensors monitoring the tumor's response to the treatment, optimizing treatment efficacy.

Novelty and Inventive Step

The new claims introduce several innovative features not present in the original patent, including reduced power consumption, cooling systems, modular designs, and real-time frequency and amplitude adjustment. These advancements provide a significant improvement over the original Optune system, addressing its inherent limitations and enhancing treatment outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different materials or designs for the implantable transducer arrays, incorporating additional sensors or feedback mechanisms, or developing specialized arrays for specific types of tumors or treatment regimens.

Potential Commercial Applications and Market

The advanced implantable TTFields delivery system has significant commercial potential in the oncology market, offering improved treatment outcomes, increased patient comfort, and reduced maintenance costs. The system could be marketed as a premium alternative to existing TTFields delivery systems, targeting hospitals, clinics, and medical research institutions.

Field of Art

Biomedical engineering, specifically medical device design for tumor treatment using electromagnetic fields, requiring advanced knowledge of electrical engineering, medical device design, and oncological treatment technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with graduate-level training in electrical engineering, medical device design, and experience with implantable medical technologies, familiar with thermal management and signal processing in medical devices

Obviousness Rationale

A person of ordinary skill would recognize that the PTD's variations represent predictable engineering improvements to the source patent's TTFields delivery system. The proposed modifications address known limitations in implantable medical device design, such as power consumption, thermal management, and adaptive treatment delivery. These enhancements would be considered routine optimization techniques within the capabilities of a skilled practitioner in the field of medical device engineering.

Obvious Combinations & Variations

Source Patent Element
Implantable electrode arrays for delivering tumor treating fields
PTD Variation
Adding a cooling system to prevent electrode element overheating
Obviousness Reasoning
Thermal management is a well-known challenge in implantable electronic devices, and a PHOSITA would find it obvious to implement cooling mechanisms to prevent potential tissue damage and improve device reliability
Source Patent Element
Fixed frequency TTFields delivery system
PTD Variation
Real-time frequency and amplitude adjustment based on tumor response sensors
Obviousness Reasoning
Adaptive treatment technologies are a predictable evolution in medical device design, with a finite set of known approaches for implementing feedback-driven treatment modulation
Source Patent Element
Integrated electrode arrays with fixed configuration
PTD Variation
Modular design allowing easy replacement and component upgrades
Obviousness Reasoning
Modular design is a standard engineering approach for improving maintainability and reducing long-term medical device costs, representing a logical design choice for a skilled practitioner
Source Patent Element
External TTFields delivery using surface electrodes
PTD Variation
Fully implantable transducer arrays with reduced power consumption
Obviousness Reasoning
Miniaturization and power efficiency are standard design goals in implantable medical technologies, with multiple known techniques for achieving reduced electrical resistance and power requirements
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857782 and the disclosed technical variations, a person having ordinary skill in the art would find the proposed improvements to TTFields delivery systems to be obvious and predictable extensions of existing medical device design principles. The variations represent routine engineering optimizations that would be apparent to a skilled practitioner without requiring inventive insight beyond the ordinary capabilities of those working in the field of medical electromagnetic treatment technologies.

Original Patent Information

Patent NumberUS 11,857,782
TitleDelivering tumor treating fields (TTFields) using implantable transducer arrays
Assignee(s)Novocure GmbH